Insider Trading July 6, 2026 06:37 PM

Kinder Morgan Executive Disposes of Shares Under Pre-Arranged Plan

V.P. Schlosser's $196,720 sale coincides with strong Q1 earnings and analyst upgrades, though stock trades near fair value estimates.

By Avery Klein
Share
Twitter Reddit Facebook LinkedIn
KMI

John W. Schlosser, Vice President and President of Terminals at Kinder Morgan, Inc. (NYSE: KMI), executed a series of share sales totaling approximately $196,720 on July 6, 2026. The transactions, conducted under a 10b5-1 trading plan established in May 2025, resulted in the disposal of 6,166 Class P Common Stock shares at a weighted average price of $31.904. Following this activity, Schlosser retains direct ownership of 164,208 shares. The sale occurs as KMI shares hover near their calculated fair value of $31.56, amidst a backdrop of robust first-quarter financial performance and renewed analyst optimism driven by strategic acquisitions and positive business developments.

Kinder Morgan Executive Disposes of Shares Under Pre-Arranged Plan
KMI
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • John W. Schlosser sold 6,166 shares for approximately $196,720 under a 10b5-1 plan adopted in May 2025.
  • Kinder Morgan reported Q1 2026 EPS of $0.48 and revenue of $4.83 billion, both exceeding forecasts.
  • UBS and Goldman Sachs reaffirmed Buy ratings with raised EBITDA estimates, citing the Monument Pipeline acquisition.

John W. Schlosser, serving as Vice President and President of Terminals at Kinder Morgan, Inc. (NYSE: KMI), recently executed a series of share transactions involving the company's Class P Common Stock. On July 6, 2026, Schlosser disposed of 6,166 shares, with the total value of these sales reaching approximately $196,720. The weighted average price per share for these transactions was recorded at $31.904. The sales were not executed as a single block but rather through multiple transactions, with individual share prices ranging from $31.7301 to $32.14. These disposals were facilitated under a pre-arranged 10b5-1 trading plan, which Schlosser initially adopted on May 7, 2025. Following the completion of these transactions, Schlosser's direct holdings in Kinder Morgan's Class P Common Stock stand at 164,208 shares.


This insider activity unfolds against a backdrop of strong financial performance and analyst sentiment. Kinder Morgan reported first-quarter 2026 earnings per share (EPS) of $0.48, surpassing the consensus forecast of $0.39. Revenue for the quarter also exceeded expectations, reaching $4.83 billion against a projected $4.63 billion. The company's stock has demonstrated resilience, delivering a 17.5% return year-to-date and maintaining a 3.76% dividend yield, supported by eight consecutive years of dividend increases according to InvestingPro data.

Analyst coverage remains constructive. UBS reiterated a Buy rating on Kinder Morgan, maintaining a $43.00 price target. The firm raised its second-quarter 2026 EBITDA estimate to $2,092 million, citing positive business developments and the impact of the Monument Pipeline acquisition. Goldman Sachs also upheld its Buy rating with a $35.00 price target, adjusting its second-quarter 2026 EBITDA estimate to $2,053 million to reflect the Monument acquisition and favorable market conditions. Conversely, Jefferies adjusted its price target downward to $34 from $36, while maintaining a Hold rating, following the strong first-quarter results.

Corporate governance developments also marked the period. At the 2026 Annual Meeting of Stockholders, shareholders elected eleven directors, including Richard D. Kinder and Kimberly A. Dang, to serve terms extending until the 2027 annual meeting. These leadership continuities underscore the company's strategic direction. Market data indicates the stock closed at $31.69, reflecting a slight decline of 0.38 or 1.17%. The stock's current trading level near the InvestingPro Fair Value of $31.56 suggests a fair valuation at present. The transaction highlights ongoing executive portfolio management within a sector experiencing capital allocation shifts and infrastructure investment cycles.

Risks

  • Stock trading near fair value of $31.56 may limit immediate upside potential despite positive earnings.
  • Jefferies lowered its price target to $34, indicating divergent analyst views on near-term valuation.
  • Execution risk associated with integrating the Monument Pipeline acquisition into financial projections.

More from Insider Trading

Palisade Bio Director Robert Baltera Jr. Expands Position as FDA Clears Phase 2 Trial Jul 6, 2026 Sight Sciences CTO David Badawi Offloads $40,858 in Company Stock Jul 6, 2026 Sight Sciences Executive Sells Stock to Cover Tax Obligations Jul 6, 2026 Sight Sciences CLO Jeremy Hayden Sells $70,133 in Stock Jul 6, 2026 Sight Sciences CFO James Rodberg Offloads $36,994 Worth of SGHT Shares Jul 6, 2026